Society for Immunotherapy of Cancer: Standards for Reporting of Multiplex Immunohistochemistry/Immunofluorescence Assays (STORMI)

Multiplex immunofluorescence and immunohistochemistry (mIF/IHC) are increasingly employed antibody-based technologies that use tissue sparingly and facilitate the detection of co-localized or neighboring biomarkers. Specifically, these platforms enable spatial analyses of the tumor microenvironment...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Ignacio I Wistuba, James L Gulley, Michael Feldman, Bernard A Fox, Jerome Galon, David B Page, James Ziai, Carlo B Bifulco, James Mansfield, Robyn Gartrell, Carmen Ballesteros-Merino, Joe Yeong, Shawn M Jensen, Sacha Gnjatic, Marc S Ernstoff, Scott J Rodig, Joel C Sunshine, Janis M Taube, David L Rimm, Magdalena Thurin, Rong Fan, Lucas A Horn, Guray Akturk, Michael Angelo, Travis J Hollmann, Jaime Rodriguez-Canales, Kurt A Schalper, Michael J Surace, Tricia R Cottrell, Roberto Salgado, Jennifer H Yearley, Arutha Kulasinghe, Edwin Parra, Sebastian Marwitz, Carlos E De Andrea, Colt Egelston, William J Howat, Jose C Villasboas, Peter Bankhead, Wiem Lassoued, Keith Wharton, Anne Hellebust, Subham Basu, Saska Brajkovic, Marco Cassano, Logan L Engle, Benjamin F Green, Stephen Hewitt, Alexander S Szalay, Sam Sater, Jorge M Blando, Denis Schapiro, Benjamin J Chen, Ahmet F Coskun, Robin H Edwards, Clifford C Hoyt, Steven Lott, George Netto, Yinyin Yuan, Geroge Zaki
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMJ Publishing Group 2025-12-01
coleção:	Journal for ImmunoTherapy of Cancer
Acesso em linha:	https://jitc.bmj.com/content/13/12/e012280.full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!